<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03420989</url>
  </required_header>
  <id_info>
    <org_study_id>casve-nm-15-220</org_study_id>
    <nct_id>NCT03420989</nct_id>
  </id_info>
  <brief_title>Elaboration of New Generation Snacks</brief_title>
  <official_title>Development of a Novel Healthy Snacks Including Seaweeds and Carob Which Improve Risk Factors Associated With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endocrinology and Clinical Nutrition Research Center, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endocrinology and Clinical Nutrition Research Center, Spain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a blind randomized clinical trial of nutritional intervention in humans with a snack
      (seaweeds and carob), compared to a control snack without the bioactive ingredients studied
      but of similar nutritional composition, to evaluate the effect on the lipid profile, glycemia
      and Insulin resistance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The design will consist of a double-blind randomized study in adult subjects with metabolic
      syndrome, who will consume snack (enriched in seaweeds and carob) (50 g / day) vs.
      conventional snack for 8 weeks.

      All the next parameters will be measured/calculated at basal time and after 8 weeks of
      intervention. The next biochemical parameters will be measured: Total cholesterol, LDL
      cholesterol, HDL, triglycerides will be analyzed using an enzyme-colorimetric method (Roche
      Diagnostics , Mannheim, Germany). Glucose will be determined by the method of glucose oxidase
      (Glucose analyzer 2, Beckman Instruments, Fullerton, California), insulin will be determined
      by Elisa (ELISA Diagnostic Corporation, Los Angeles, CA) and HOMA will be calculated by the
      formula Matthew et al. , 1985 (HOMA = (glucose * insulin) / 22.5). Body weight and fat mass
      by bioimpedance will be measured, too. Blood pressure (Systolic and diastolic blood pressure)
      will be measured, too. A diet records for 3 days and a satiety scale will be performed at the
      beginning and end of the intervention period.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lipoproteins</measure>
    <time_frame>change from baseline HDL cholesterol (mg/dl) and LDL cholesterol (mg/dl )levels at 8 weeks</time_frame>
    <description>change in serum lipoprotein levels such as HDL-cholesterol and LDL cholesterol (mg/dl)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>carbohydrate metabolism</measure>
    <time_frame>change from baseline fasting glucose levels (mg/dl) at 8 weeks</time_frame>
    <description>change of seric carbohydrate parameters markers such as fasting glucose levels (mg/dl)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>carbohydrate metabolism</measure>
    <time_frame>change from baseline insulin levels (UI/L) at 8 weeks</time_frame>
    <description>change of seric carbohydrate parameters markers such as insulin levels (UI/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>carbohydrate metabolism</measure>
    <time_frame>change from baseline HOMA-Insulin Resistance (units) at 8 weeks</time_frame>
    <description>change of seric carbohydrate parameters markers such as HOMA-Insulin resistance (units)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>change from baseline systolic blood pressure (mmHg) and diastolic blood pressure (mmHg) at 8 weeks</time_frame>
    <description>change of systolic blood pressure (mmHg) and diastolic blood pressure (mmHg)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Snack Food</condition>
  <arm_group>
    <arm_group_label>Active snack food</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>snack food with carob and seaweeds 50 gr per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control snack food</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>snack food without carob and seaweeds 50 gr per day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active snack food</intervention_name>
    <description>snack enriched with seaweeds and carob</description>
    <arm_group_label>Active snack food</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control snack food</intervention_name>
    <description>the same snack food without seaweeds and carob</description>
    <arm_group_label>Control snack food</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of metabolic syndrome by (Adult Treatment Panel III) criteria

        Exclusion Criteria:

          -  consume supplements (vitamins, minerals or other dietary components),

          -  non-restrictive diet

          -  known chronic disease (eg diabetes, cardiovascular disease, Inflammatory diseases).

          -  active cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Daniel de Luis Roman</name>
      <address>
        <city>Valladolid</city>
        <zip>47003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel de Luis Roman, MD Ph</last_name>
      <phone>670560484</phone>
      <phone_ext>86660</phone_ext>
      <email>dadluis@yahoo.es</email>
    </contact>
    <contact_backup>
      <last_name>Rocio Allerde la Fuente, MD Ph</last_name>
      <phone>680251083</phone>
      <phone_ext>86660</phone_ext>
      <email>roaller@yahoo.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2016</study_first_submitted>
  <study_first_submitted_qc>February 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2018</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Endocrinology and Clinical Nutrition Research Center, Spain</investigator_affiliation>
    <investigator_full_name>Daniel de Luis Roman</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>carob</keyword>
  <keyword>seaweed</keyword>
  <keyword>snack food</keyword>
  <keyword>obese subjects</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Locust bean gum</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

